<?xml version="1.0" encoding="UTF-8"?>
<p id="p0105">The use of corticosteroids would be contraindicated in the first phase of the disease, but may play a role in the second phase, the one characterized by potential rapidly progressive lung involvement and secondary to hyperinflammatory syndrome and cytokine release syndrome. Of note, data suggest a significant impact on the survival curves of patients with COVID-19 infection who have developed acute respiratory distress syndrome.
 <xref rid="bib16" ref-type="bibr">
  <sup>16</sup>
 </xref>
</p>
